Effect of the N-acetyl cysteine versus placebo on prevention and control of chemotherapy induced neuropathy in patients with breast cancer

Phase 3

Recruiting

• Conditions: europathy.; Idiopathic progressive neuropathy; G60.3

• Registration Number: IRCT20120215009014N377
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 102

Inclusion Criteria

Age: 18 to 80 years old
Candidate for chemotherapy

Exclusion Criteria

History of neuropathy with grade greater than one
Behavioral disorders
History of chemotherapy
History of asthma

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of neuropathy. Timepoint: Before chemotherapy and three weeks after that. Method of measurement: Using the NCI-CTCAE v4.0 scale and Visual Analog Scale (VAS).